AK Medical Holdings Limited
Chinese orthopedic implant manufacturer that commercialized 3D printing technology for joint replacement, spine, and trauma implants; listed on Hong Kong Stock Exchange (1789.HK)
- CEO / Founder
- Li Zhijiang (李志疆)
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- $56M
- Latest Round
- IPO
- Key Investors
- Public shareholders (HKEX); OrbiMed (pre-IPO investor)
Technology & Products
Key Products
3D-printed hip replacement implants (acetabular cups, femoral stems); 3D-printed knee prostheses (including first metal 3D-printed tibial tray in China); 3D-printed spinal interbody cages and artificial vertebral bodies; 3D-printed customized implants for complex cases (tumor, trauma); ICOS (Innovative Custom Orthopedic Solution) personalized platform; VTS (Visual Treatment Solution) intelligent surgical planning; iBot surgical robot; Supravit HA-coated implants via JRI
Technological Advantage
Four proprietary technology platforms: (1) 3D ACT metal additive manufacturing for bone-like porous structures; (2) Supravit vacuum plasma spraying (VPS) HA coating via JRI; (3) Smart orthopedic technology (VTS/IBot surgical robots); (4) ICOS personalized orthopedic solutions. Asia's largest 3D printing base for orthopedics with 8 GE Additive Arcam EBM systems. 600+ patents globally.
Differentiation
Value Proposition
World's first company to commercialize additive manufacturing (3D printing) for orthopedic implants, offering a comprehensive portfolio of hip, knee, spine, and trauma implants with 3D-printed bone-like trabecular structures that promote osseointegration
How They Differentiate
First-mover advantage in 3D-printed orthopedic implants with the most extensive clinical track record; Asia's largest dedicated 3D printing facility for orthopedics; only Chinese orthopedic company with full 3D printing commercialization across hip, knee, spine, and trauma; vertically integrated with UK R&D and manufacturing (JRI) for global reach
Market & Competition
Target Customers
Hospitals, orthopedic surgeons, and healthcare institutions globally; patients requiring joint replacement, spine surgery, and trauma reconstruction
Industry Verticals
Orthopedic surgery (joint replacement, spine, trauma, tumor reconstruction)
Competitors
Chunli Medical (春立医疗); Weigao Orthopedics (威高骨科); Dabo Medical (大博医疗)
Growth & Milestones
Growth Metrics
FY2025 revenue: RMB 1.482B (~$205M), +10.1% YoY; FY2024 revenue: RMB 1.346B; Net profit FY2025: RMB 339M; 1.2M+ implants placed globally; one implant every 2 minutes
Major Milestones
2003: Founded; 2009: Began 3D printing R&D for orthopedics; 2015: First NMPA-approved 3D-printed hip implant system in China; 2017: IPO on HKEX (1789.HK); 2018: Acquired JRI Orthopaedics (UK); 2020: Acquired Beijing Libeier (formerly Medtronic subsidiary); 2023: Launched TCBridge 3D-printed customized long bone defect repair system; 2024: 3D printing & smart manufacturing base groundbreaking in Changping, Beijing
Notable Customers
7,500+ hospitals across 40+ countries including China, UK, Japan, South Korea, Spain, South Africa